Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » chlamydia

chlamydia

Oct 23, 2014

Cepheid Q3 Sales Rise 15 Percent as Firm Lands Major Reference Lab Customers

Premium

NEW YORK (GenomeWeb) — Cepheid said last week that its third quarter revenues grew 15 percent year over year driven primarily by stronger than expected commercial clinical revenue resulting from new Xpert assays and customer types.

Aug 21, 2014

Startup Diassess Wins New NIH Grant to Develop POC Nucleic Acid Test for Chlamydia

Premium

NEW YORK (GenomeWeb) — Bay Area startup Diassess has been awarded nearly $300,000 from the National Institutes of Health for the first year of a two-year project to develop a point-of-care, nucleic acid amplification-based diagnostic device for sexually transmitted infections, with an initial foc

Jul 31, 2014

Hologic's Q3 Revenues Rise 1 Percent; Firm Raises Guidance

NEW YORK (GenomeWeb) – Hologic said after the close of the market on Wednesday that its revenues for the fiscal third quarter inched up 1 percent year over year.

Jul 29, 2014

U of Maryland Wins $10.7M for STI/STD Center, Omics Research Projects

NEW YORK (GenomeWeb) – The University of Maryland's Schools of Dentistry and Medicine said today they have jointly received a $10.7 million grant from the National Institute of Allergy and Infectious Diseases to use omics methods to identify molecular biomarkers related to sexually transmitted in

Jul 28, 2014

FDA Clears BD Chlamydia, Gonorrhea Assays

NEW YORK (GenomeWeb) – BD Diagnostics said today the US Food and Drug Administration has cleared for marketing the BD ProbeTec Chlamydia trachomatis Qx Amplified DNA Assay and the BD ProbeTec Neisseria gonorrhea Qx Amplified DNA Assay on the BD Viper LT system.

Apr 29, 2014

Atlas Genetics Completes Final Tranche of $28.4M Series B Financing

NEW YORK (GenomeWeb) – Atlas Genetics today announced it completed the final tranche of its £16.9 million ($28.4 million) Series B financing to complete the transfer to manufacture of its io molecular diagnostics system and file for regulatory approval of the first test for chlamydia.

Feb 27, 2014

Wave 80 Receives SBIR Grant to Develop No-spin Sample Prep for Chlamydia MDx

Premium

Molecular diagnostic company Wave 80 Biosciences has received Phase I Small Business Innovation Research funding from the National Institutes of Health to develop rapid sample prep to support chlamydia testing in low-resource settings.

Feb 11, 2014

Quidel Q4 Revenues Shrink 7 Percent on Softer Flu Business; MDx Projects Remain on Track

NEW YORK (GenomeWeb News) – Quidel reported after the close of the market on Tuesday that its fourth quarter revenues declined 7 percent year over year on slower influenza and respiratory disease business.

Feb 06, 2014

New Hologic CEO Sees Promise in Former Gen-Probe Unit as Firm Seeks Return to Organic Growth

Premium

Hologic this week reported a 3 percent year-over-year decline in fiscal first-quarter revenues, including a 7 percent drop in revenues in its Diagnostics division.

Dec 12, 2013

Estonian Group Validates Point-of-Care Chlamydia Assay Featuring Isothermal RPA Technology

Premium

A team from Estonia's University of Tartu and molecular diagnostics startup Selfdiagnostics has published a peer-reviewed study describing and clinically validating a recently developed point-of-care molecular assay to diagnose chlamydia infections.

Pages

The Scan

Director of Both, For Now

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

Behind on Testing

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

From CRISPR Lab to COVID-19 Lab

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

Nature Papers Present New CRISPR Screening Approach, Discuss CRISPR in Crop Breeding, More

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.